MedPath

Effect of the consumption of a fermented dairy product onconstipation in childhood: a multi-centre randomizedcontrolled trial.

Suspended
Conditions
Childhood constipation
Registration Number
NL-OMON24332
Lead Sponsor
Danone Research
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Not specified
Target Recruitment
160
Inclusion Criteria

1. Children (boys and girls) aged from 3 to 16 years

2. Children with a diagnosis of functional constipation according to Rome III
criteria (Rasquin et al.):

Exclusion Criteria

1. Children with a diagnosis of IBS according to Rome III criteria

2. Children treated for constipation less than 2 weeks before intake in the
study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint is the stool frequency change from baseline to 3 weeks of product consumption.
Secondary Outcome Measures
NameTimeMethod
Stool frequency over 3 weeks and at week 1 and 2 of product consumption.<br /><br>- Stool consistency over 3 weeks and per week of product consumption.<br /><br>- Frequency of episodes of faecal incontinence over 3 weeks and per week of product<br>consumption.<br /><br>- Pain during defecation over 3 weeks and per week of product consumption.<br /><br>- Digestive symptoms: abdominal pain and flatulence over 3 weeks and per week of product<br>consumption.<br /><br>- Adverse effects: nausea, diarrhoea and bad taste over 3 weeks and per week of product<br>consumption.<br /><br>- Intake of Bisacodyl over 3 weeks and per week of product consumption.<br /><br>- Rate of success defined as 3 or more bowel movements per week and less than 1 faecal<br>incontinence episode in 2 weeks over the last 2 weeks of product consumption<br /><br>- Rate of responders defined as a subject who reports a stool frequency ¡Ý 3 on the last week of product consumption<br>
© Copyright 2025. All Rights Reserved by MedPath